Transcat (TRNS) Director Christopher P. Gillette Exercises RSUs, Sells 1,587 Shares

What Happened
Christopher P. Gillette, a director of Transcat Inc. (TRNS), had derivative awards convert and move through two actions: on 2026-09-10 he exercised/converted 1,587 derivative units into common shares and disposed of (sold/transfered) those 1,587 shares the same day. The filing also shows a grant of 1,671 restricted stock units (RSUs) on 2026-09-09. All transactions report $0.00 per-share in the filing (conversion/grant reporting); the Form 4 excerpt does not disclose cash proceeds or a sale price for the disposed shares.

Key Details

• Transaction dates: RSU grant on 2026-09-09 (1,671 RSUs, A); conversion/exercise and disposition on 2026-09-10 (1,587 shares, M acquired and M disposed).
• Reported price: $0.00 per share for the award/conversion entries in the filing; no sale proceeds or sale price shown in the provided excerpt.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnotes of note:
  • F1: RSUs convert one-for-one into common stock.
  • F2: The 1,671 RSU grant was reported as exempt under Rule 16b-3 and generally vests 9/09/2027 (per filing).
  • F3: A set of RSUs vested on 9/10/2026 (applies to the converted 1,587 shares).
  • F4: Describes a separate option vesting schedule (1/5 per year) referenced in the filing.
• Timeliness: Filing date 2026-09-10 for transactions dated 9/09–9/10; no late filing flag shown in the excerpt.

Context
These transactions involve derivative awards (RSUs) converting to common stock and an immediate disposal of the converted shares on the same day. Form 4 derivative entries commonly show $0.00 for the conversion/grant step; the filing excerpt does not provide the cash consideration or market sale price for the disposed shares, so the monetary value of the sale is not shown here. This is a director-level filing (not a 10% beneficial owner disclosure).